Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper
| Autor: | Philip N. Newsome, Markus Cornberg, Thomas Berg, Tobias Boettler, Mario U. Mondelli, Elisa Cordero, Mojca Maticic |
|---|---|
| Přispěvatelé: | Boettler, Tobias, Maticic, Mojca, Cordero, Elisa, Cornberg, Markus, Boettler, Tobias [0000-0002-1195-055X], Maticic, Mojca [0000-0003-4261-0424], Cordero, Elisa [0000-0001-7766-7266], Cornberg, Markus [0000-0002-9141-8001], Universidad de Sevilla. Departamento de Medicina |
| Rok vydání: | 2020 |
| Předmět: |
ACE-I
angiotensin-converting enzyme inhibitor NAFLD non-alcoholic fatty liver disease medicine.medical_specialty Telemedicine NASH non-alcoholic steatohepatitis PIs protease inhibitors medicine.medical_treatment AST aspartate aminotransferase EGD esophagogastroduodenoscopy Liver transplantation ACE2 angiotensin-converting enzyme 2 Chronic liver disease SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 Article MELD model for end-stage liver disease Liver disease ULN upper limit of normal Model for End-Stage Liver Disease Baricitinib ALT alanine aminotransferase Health care Pandemic Internal Medicine Immunology and Allergy Medicine Pharmacokinetics RdRp RNA-dependent RNA polymerase lcsh:RC799-869 NUC nucleoside analogue Intensive care medicine COVID-19 coronavirus disease 2019 Hepatology business.industry Gastroenterology medicine.disease Coronavirus ERC endoscopic retrograde cholangiography ACLF acute-on-chronic liver failure Position paper lcsh:Diseases of the digestive system. Gastroenterology HCC hepatocellular carcinoma business |
| Zdroj: | JHEP Reports Digital.CSIC. Repositorio Institucional del CSIC instname JHEP Reports, Vol 2, Iss 3, Pp-(2020) |
| ISSN: | 2589-5559 |
| DOI: | 10.1016/j.jhepr.2020.100113 |
| Popis: | The coronavirus disease 2019 (COVID-19) pandemic poses an enormous challenge to healthcare systems in affected communities. Older patients and those with pre-existing medical conditions have been identified as populations at risk of a severe disease course. It remains unclear at this point to what extent chronic liver diseases should be considered as risk factors, due to a shortage of appropriate studies. However, patients with advanced liver disease and those after liver transplantation represent vulnerable patient cohorts with an increased risk of infection and/or a severe course of COVID-19. In addition, the current pandemic requires unusual allocation of healthcare resources which may negatively impact the care of patients with chronic liver disease that continue to require medical attention. Thus, the challenge hepatologists are facing is to promote telemedicine in the outpatient setting, prioritise outpatient contacts, avoid nosocomial dissemination of the virus to patients and healthcare providers, and at the same time maintain standard care for patients who require immediate medical attention. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|